Herpes simplex virus and pregnancy: A review of the management of antenatal and peripartum herpes infections

Obstetrical and Gynecological Survey

Volumn 66, Issue 10, 2011, Pages 629-638

  Westhoff, Gina L ^a   Little, Sarah E ^b   Caughey, Aaron B ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FAMCICLOVIR; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; VALACICLOVIR;

AGE DISTRIBUTION; AMNIOCENTESIS; ANTIVIRAL THERAPY; BLOOD SAMPLING; CESAREAN SECTION; CLINICAL FEATURE; CONGENITAL INFECTION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DRUG SAFETY; FETUS MONITORING; FLUORESCENT ANTIBODY TECHNIQUE; GENITAL HERPES; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION RISK; INTRAUTERINE INFECTION; LABOR; NEONATAL HERPES INFECTION; NEWBORN INFECTION; PERINATAL PERIOD; PERIPARTUM INFECTION; PERIUMBILICAL BLOOD SAMPLING; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE FETUS MEMBRANE RUPTURE; PRENATAL DIAGNOSIS; RECURRENT INFECTION; REVIEW; SCREENING; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE; TZANCK PREPARATION; VAGINAL DELIVERY; VERTICAL TRANSMISSION; VIRUS CULTURE; VIRUS DIAGNOSIS; VIRUS SHEDDING; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; CESAREAN SECTION; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEXUALLY TRANSMITTED DISEASES;

EID: 83055196713     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e31823983ec     Document Type: Review

References (49)

1. Centers for Disease Control. Seroprevalence of herpes simplex virus type 2 among persons aged 14-49-United States, 2005-2008. Morbid Mortal Wkly Report. 2010;59:456-459.
2. Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis. 2003;30:797-800. (Pubitemid 37229492)
3. Pena K, Adelson M, Mordechai E, et al. Genital herpes simplex virus type 1 in women: detection in cervicovaginal specimens from gynecologic practices in the Unites States. J Clin Micro. 2010;48:150-153.
4. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997;337:509-515. (Pubitemid 27352016)
5. Kulhanjian JA, Soroush V, Au DS, et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med. 1992; 326:916-920.
6. Kimberlin DW, Rouse DJ. Clinical practice. Genital herpes. N Engl J Med. 2004;350:1970-1977.
7. Practice Bulletin No. 82. Management of Herpes in Pregnancy. ACOG. 2007;109:1233-1248.
8. Epidemiology, clinical manifestations and diagnosis of genital herpes simplex virus infection. UpToDate, 2011. Available at: http://www.utdol.com/utd/ content/topic.do?topicKey-viral-in/9311&type-A&selectedTitle-5-87.
9. Corey L, Adams HG, Brown ZA, et al. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med. 1983;98:958-972. (Pubitemid 13053413)
10. Whitley RJ, Kimberlin DW, Roizman B. Herpes simplex viruses. Clin Infect Dis. 1998;26:541-553; quiz 54-55.
11. Brown ZA, Gardella C, Wald A, et al. Genital herpes complicating pregnancy. Obstet Gynecol. 2005;106:845-856. (Pubitemid 41362194)
12. Gynecologists A. Practice bulletin: gynecological herpes simplex virus infections. Int J Gynecol Obstet. 2004;57: 1111-1117.
13. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med. 2000;342:844-850. (Pubitemid 30165207)
14. Brock BV, Selke S, Benedetti J, et al. Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes. JAMA. 1990;263:418-420. (Pubitemid 20026017)
15. Koutsky LA, Stevens CE, Holmes KK, et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med. 1992;326:1533-1539.
16. Mosely RC, Corey L, Benjamin D, et al. Comparison of viral isolation, direct immunofluorescene and indirect immunoperoxidase techniques for detection of genital herpes simplex virus infection. J Clin Microbiol. 1981;13:913-918. (Pubitemid 11094081)
17. Wald A, Huang M, Carrell D, et al. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis. 2003;188:1345-1351. (Pubitemid 37433705)
18. Chan EL, Brandt K, Horsman GB. Comparison of Chemicon SimulFluor direct fluorescent antibody staining with cell culture and shell vial direct immunoperoxidase staining for detection of herpes simplex virus with cystospin direct immunofluorescence staining for detection of varicella-zoster virus. Clin Diagn Lab Immunol. 2001;8:909-912. (Pubitemid 32868306)
19. Folkers E, Oranje AP, Duivenvoorden JN, et al. Tzanck smear in diagnosing genital herpes. Genitourin Med. 1988;64:249-245.
20. Wald A, Ashley-Morrow R. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. Clin Infect Dis. 2002; 15:S173-S182. (Pubitemid 35178328)
21. Stone KM, Reiff-Eldridge R, White AD, et al. Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984-1999. Birth Defects Res A Clin Mol Teratol. 2004;70: 201-207. (Pubitemid 38581386)
22. Andrews WW, Kimberlin DF, Whitley R, et al. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Am J Obstet Gynecol. 2006;194:774-781. (Pubitemid 43333153)
23. Pasternak B, Hviid A. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defect. JAMA. 2010;304:859-866.
24. Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev. 2004;17:1-13. (Pubitemid 38120927)
25. Corey L, Wald A. Maternal neonatal herpes simplex virus infections. N Engl J Med. 2009;361:1376-1385.
26. Brown ZA, Wald A, Morrow RA, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA. 2003;289:203-209. (Pubitemid 36068708)
27. Baker DA. Consequences of herpes simplex virus in pregnancy and their prevention. Curr Opin Infect Dis. 2007;20: 73-76. (Pubitemid 46052130)
28. Rudnik CM, Hoekzema GS. Neonatal herpes simplex virus infections. Am Fam Physician. 2002;6:1138-1142.
29. Gardella C, Brown ZA, Wald A, et al. Poor correlation between genital lesions and detection of herpes simplex virus in women in labor. Obstet Gynecol. 2005;106:268-274. (Pubitemid 41023262)
30. Randolph AG, Washington AE, Prober CG. Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs. JAMA. 1993;270:77-82. (Pubitemid 23202656)
31. Randolph AG, Hartshorn RM, Washington AE. Acyclovir prophylaxis in late pregnancy to prevent neonatal herpes: a cost-effectiveness analysis. Obstet Gynecol. 1996;88(4 pt 1): 603-610. (Pubitemid 26326027)
32. Major CA, Towers CV, Lewis DF, et al. Expectant management of preterm premature rupture of membranes complicated by active recurrent genital herpes. Am J Obstet Gynecol. 2003;188:1551-1554; discussion 4-5.
33. Hollier LM, Wendel GD. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. The Cochrane Collaboration. 2008:1-20.
34. Little SE, Caughey AB. Acyclovir prophylaxis for pregnant women with a known history of herpes simplex virus: a cost-effectiveness analysis. Am J Obstet Gynecol. 2005; 193(3 pt 2):1274-1279. (Pubitemid 41285533)
35. Kimberlin DW, Lin CY, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001;108:223-229.
36. Enright AM, Prober CG. Neonatal herpes infection: diagnosis, treatment and prevention. Seminin Neonatol. 2002;7:283-291. (Pubitemid 35238721)
37. Whitley R. Neonatal herpes simplex virus infection. Curr Opin Infect Dis. 2004;17:243-246. (Pubitemid 38703854)
38. Cleary KL, Pare E, Stamilio D, et al. Type-specific screening for asymptomatic herpes infection in pregnancy: a decision analysis. BJOG. 2005;112:731-736. (Pubitemid 40852840)
39. Tuite AR, McCabe CJ, Ku J, et al. Projected cost-savings with herpes simplex virus screening in pregnancy: towards a new screening paradigm. Sex Transm Infect. 2011;87:141-148.
40. Baker D, Brown Z, Hollier LM, et al. Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy. Am J Obstet Gynecol. 2004;191:2074-2084. (Pubitemid 39601516)
41. Thung SF, Grobman WA. The cost-effectiveness of routine antenatal screening for maternal herpes simplex virus-1 and-2 antibodies. Am J Obstet Gynecol. 2005;192:483-488. (Pubitemid 40214984)
42. Barnabas RV, Carabin H, Garnett GP. The potential role of suppressive therapy for sex partners in the prevention of neonatal herpes: a health economic analysis. Sex Transm Infect. 2002;78:425-429. (Pubitemid 36020816)
43. Rouse DJ, Stringer JS. An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes. Am J Obstet Gynecol. 2000;183:400-406. (Pubitemid 30651088)
44. Corey L, Wald A, Celum CL, et al. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr. 2004;35:435-445. (Pubitemid 38420652)
45. Chen KT, Segu M, Lumey LH, et al. Genital herpes simplex virus infection and perinatal transmission of human immunodeficiency virus. Obstet Gynecol. 2005;106:1341-1348. (Pubitemid 41668955)
46. Cowan FM, Humphrey JH, Ntozini R, et al. Maternal herpes simplex virus type 2 infections, syphilis and risk of intrapartum transmission of HIV-1: results of a case control study. AIDS. 2008;22:193-201.
47. Nagot N, Ouedrago A, Foulonge V, et al. Reduction in HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med. 2007;356:790-799. (Pubitemid 46294611)
48. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med. 2008;358:1560-1571. (Pubitemid 351519816)
49. Celum C, Wald A, Hughes J, et al. Effect of acyclovir on HIV-1 acquisition in herpes simplex virus 2 sero-positive women and men who have sex with men: a randomized, double-blind, placebo-controlled trial. Lancet. 2008;371:2109-2119. (Pubitemid 351902179)